Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Year
2019
Referencia
BMC Cancer. 2019 Jan 7;19(1):12. doi: 10.1186/s12885-018-5203-y.
Tipus publicació
Paper in international publication
DOI
http://dx.doi.org/10.1186/s12885-018-5203-y
Revista
BMC CANCER
Títol Complet
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program.
Factor d'impacte
2.93
Codi
11173
PMID
https://pubmed.ncbi.nlm.nih.gov/30612558
Nom Autors
Heidenreich, Axel, Gillessen, Silke, Heinrich, Daniel, Keizman, Daniel, O'Sullivan, Joe M, Carles, Joan, Wirth, Manfred, Miller, Kurt, Reeves, John, Seger, Monica et al.
DOI número
10.1186/s12885-018-5203-y
Year
2019
Referencia
J Neurol. 2019 Mar;266(3):598-608. doi: 10.1007/s00415-018-09172-1. Epub 2019 Jan 8.
Tipus publicació
Paper in international publication
DOI
http://dx.doi.org/10.1007/s00415-018-09172-1
Revista
JOURNAL OF NEUROLOGY
Títol Complet
Clinical effect of successful reperfusion in patients presenting with NIHSS < 8: data from the BEYOND-SWIFT registry.
Factor d'impacte
4.20
Codi
11174
PMID
https://pubmed.ncbi.nlm.nih.gov/30617997
Nom Autors
Kaesmacher, Johannes, Chaloulos-Iakovidis, Panagiotis, Panos, Leonidas, Mordasini, Pasquale, Heldner, Mirjam R, Kurmann, Christoph C, Michel, Patrik, Hajdu, Steven D, Ribo, Marc, Requena, Manuel et al.
DOI número
10.1007/s00415-018-09172-1
Year
2019
Referencia
Hepatology. 2019 Jan;69(1):282-293. doi: 10.1002/hep.30182. Epub 2018 Dec 10.
Tipus publicació
Paper in international publication
DOI
http://dx.doi.org/10.1002/hep.30182
Revista
HEPATOLOGY
Títol Complet
Preemptive-TIPS improves outcome in high-risk variceal bleeding: An observational study.
Factor d'impacte
14.97
Codi
11175
PMID
https://pubmed.ncbi.nlm.nih.gov/30014519
Nom Autors
Nevens, Frederik, Castellote, Jose, Rodrigues, Susana, Gluud, Lise L, Noronha Ferreira, Carlos, Barcelo, Rafael, Canete, Nuria, Rodriguez, Manuel, Ferlitsch, Arnulf, Mundi, Jose Luis et al.
DOI número
10.1002/hep.30182
Year
2019
Referencia
Hepatology. 2019 Jan;69(1):455-457. doi: 10.1002/hep.30180. Epub 2018 Dec 28.
Tipus publicació
Paper in international publication
DOI
http://dx.doi.org/10.1002/hep.30180
Revista
HEPATOLOGY
Títol Complet
Patients with compensated cirrhosis are also at risk of falling.
Factor d'impacte
14.97
Codi
11176
PMID
https://pubmed.ncbi.nlm.nih.gov/30014491
Nom Autors
Roman, Eva, Gely, Cristina, Flavia, Montse, Poca, Maria, Alvarado, Edilmar, Vargas, Victor, Guarner, Carlos, Soriano, German et al.
DOI número
10.1002/hep.30180
Year
2019
Referencia
Future Oncol. 2019 Feb;15(4):345-347. doi: 10.2217/fon-2018-0760. Epub 2019 Jan 8.
Tipus publicació
Paper in international publication
DOI
http://dx.doi.org/10.2217/fon-2018-0760
Revista
Future Oncology
Títol Complet
Could JAG1 protein inhibition prevent colorectal cancer?
Factor d'impacte
2.28
Codi
11177
PMID
https://pubmed.ncbi.nlm.nih.gov/30620224
Nom Autors
Lopez-Arribillaga, Erika, Rodilla, Veronica, Espinosa, Lluis et al.
DOI número
10.2217/fon-2018-0760
Year
2019
Referencia
Clin Transl Oncol. 2019 Jan;21(1):31-45. doi: 10.1007/s12094-018-02010-w. Epub 2019 Jan 8.
Tipus publicació
Paper in international publication
DOI
http://dx.doi.org/10.1007/s12094-018-02010-w
Revista
Clinical & Translational Oncology
Títol Complet
SEOM clinical guidelines in advanced and recurrent breast cancer (2018).
Factor d'impacte
2.44
Codi
11178
PMID
https://pubmed.ncbi.nlm.nih.gov/30617924
Nom Autors
Chacon Lopez-Muniz, J I, de la Cruz Merino, L, Gavila Gregori, J, Martinez Duenas, E, Oliveira, M, Segui Palmer, M A, Alvarez Lopez, I, Antolin Novoa, S, Bellet Ezquerra, M, Lopez-Tarruella Cobo, S et al.
DOI número
10.1007/s12094-018-02010-w
Year
2019
Referencia
Acta Otorrinolaringol Esp. 2019 Nov - Dec;70(6):364-372. doi: 10.1016/j.otorri.2018.06.008. Epub 2019 Jan 5.
Tipus publicació
Paper in national publication
DOI
http://dx.doi.org/10.1016/j.otorri.2018.06.008
Revista
Acta otorrinolaringologica espanola
Títol Complet
Clinical Practice Guideline recommendations on examination of the upper airway for adults with suspected obstructive sleep apnoea-hypopnoea syndrome.
Factor d'impacte
0.00
Codi
11179
PMID
https://pubmed.ncbi.nlm.nih.gov/30616837
Nom Autors
Esteller, Eduard, Carrasco, Marina, Diaz-Herrera, Miguel Angel, Sampol, Gabriel, Juvanteny, Joan, Sieira, Ramon, Farre, Alex, Vilaseca, Isabel, Vila, Javier et al.
DOI número
10.1016/j.otorri.2018.06.008
Year
2019
Referencia
Eur J Cancer. 2019 Jan;107:142-152. doi: 10.1016/j.ejca.2018.11.015. Epub 2018 Dec 18.
Tipus publicació
Paper in international publication
DOI
http://dx.doi.org/10.1016/j.ejca.2018.11.015
Revista
EUROPEAN JOURNAL OF CANCER
Títol Complet
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with >/=25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy.
Factor d'impacte
6.68
Codi
11180
PMID
https://pubmed.ncbi.nlm.nih.gov/30576970
Nom Autors
Jang, Raymond W, Wong, Stuart, Keilholz, Ulrich, Gilbert, Jill, Fenton, Moon, Brana, Irene, Henry, Stephanie, Remenar, Eva, Papai, Zsuzsanna, Siu, Lillian L et al.
DOI número
10.1016/j.ejca.2018.11.015
Year
2019
Referencia
BMC Med. 2019 Jan 9;17(1):8. doi: 10.1186/s12916-018-1233-1.
Tipus publicació
Paper in international publication
DOI
http://dx.doi.org/10.1186/s12916-018-1233-1
Revista
BMC Medicine
Títol Complet
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial.
Factor d'impacte
8.29
Codi
11181
PMID
https://pubmed.ncbi.nlm.nih.gov/30621698
Nom Autors
Canes, Jordi, Gavila, Joaquin, Oliveira, Mafalda, Pascual, Tomas, Perez-Garcia, Jose, Gonzalez, Xavier, Ciruelos, Eva, Munoz, Montserrat, Virizuela, Juan A, Ruiz, Isabel et al.
DOI número
10.1186/s12916-018-1233-1
Year
2019
Referencia
J Am Coll Cardiol. 2019 Jan 8;73(1):89-99. doi: 10.1016/j.jacc.2018.09.086.
Tipus publicació
Review in national publication
DOI
http://dx.doi.org/10.1016/j.jacc.2018.09.086
Revista
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Títol Complet
Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week.
Factor d'impacte
18.64
Codi
11182
PMID
https://pubmed.ncbi.nlm.nih.gov/30621955
Nom Autors
Garcia-Dorado, David, Yellon, Derek M, Davidson, Sean M, Ferdinandy, Peter, Andreadou, Ioanna, Botker, Hans Erik, Heusch, Gerd, Ibanez, Borja, Ovize, Michel, Schulz, Rainer et al.
DOI número
10.1016/j.jacc.2018.09.086
Year
2019
Referencia
Mult Scler Relat Disord. 2019 Feb;28:230-234. doi: 10.1016/j.msard.2019.01.007. Epub 2019 Jan 3.
Tipus publicació
Paper in international publication
DOI
http://dx.doi.org/10.1016/j.msard.2019.01.007
Revista
Multiple Sclerosis and Related Disorders
Títol Complet
Frequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease.
Factor d'impacte
2.73
Codi
11183
PMID
https://pubmed.ncbi.nlm.nih.gov/30623863
Nom Autors
Sepulveda, Maria, Armangue, Thais, Sabater, Lidia, Martinez-Hernandez, Eugenia, Arrambide, Georgina, Blanco, Yolanda, Llufriu, Sara, Martinez-Lapiscina, Elena H, Mulero, Patricia, Sola-Valls, Nuria et al.
DOI número
10.1016/j.msard.2019.01.007
Year
2019
Referencia
Ann Oncol. 2019 Jul 1;30(7):1179. doi: 10.1093/annonc/mdy535.
Tipus publicació
Letter or abstract
DOI
http://dx.doi.org/10.1093/annonc/mdy535
Revista
ANNALS OF ONCOLOGY
Títol Complet
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.
Factor d'impacte
14.20
Codi
11184
PMID
https://pubmed.ncbi.nlm.nih.gov/30624662
Nom Autors
Cortes, J, Calvo, V, Ramirez-Merino, N, O'Shaughnessy, J, Brufsky, A, Robert, N, Vidal, M, Munoz, E, Perez, J, Dawood, S et al.
DOI número
10.1093/annonc/mdy535
Year
2019
Referencia
Ann Oncol. 2019 Jun 1;30(6):1017. doi: 10.1093/annonc/mdy529.
Tipus publicació
Letter or abstract
DOI
http://dx.doi.org/10.1093/annonc/mdy529
Revista
ANNALS OF ONCOLOGY
Títol Complet
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer.
Factor d'impacte
14.20
Codi
11185
PMID
https://pubmed.ncbi.nlm.nih.gov/30624616
Nom Autors
Baselga, J, Manikhas, A, Cortes, J, Roman, L, Semiglazov, V F, Byakhov, M, Lokanatha, D, Forenza, S, Goldfarb, R H, Matera, J et al.
DOI número
10.1093/annonc/mdy529
Year
2019
Referencia
Ann Oncol. 2019 Jun 1;30(6):1020. doi: 10.1093/annonc/mdy532.
Tipus publicació
Letter or abstract
DOI
http://dx.doi.org/10.1093/annonc/mdy532
Revista
ANNALS OF ONCOLOGY
Títol Complet
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors.
Factor d'impacte
14.20
Codi
11186
PMID
https://pubmed.ncbi.nlm.nih.gov/30624604
Nom Autors
Andreis, D De, Ropert, S, Lopez, E, Catteau, A, James, J, Marier, J-F, Beliveau, M, Martell, R E, Baselga, J, Armand, J-P et al.
DOI número
10.1093/annonc/mdy532
Year
2019
Referencia
Ann Oncol. 2019 Jul 1;30(7):1178. doi: 10.1093/annonc/mdy534.
Tipus publicació
Letter or abstract
DOI
http://dx.doi.org/10.1093/annonc/mdy534
Revista
ANNALS OF ONCOLOGY
Títol Complet
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors.
Factor d'impacte
14.20
Codi
11187
PMID
https://pubmed.ncbi.nlm.nih.gov/30624599
Nom Autors
Baselga, J, Serrano, C, Cortes, J, De Mattos-Arruda, L, Bellet, M, Gomez, P, Saura, C, Perez, J, Vidal, M, Munoz-Couselo, E et al.
DOI número
10.1093/annonc/mdy534
Year
2019
Referencia
Ann Oncol. 2019 Aug 1;30(8):1404. doi: 10.1093/annonc/mdy538.
Tipus publicació
Letter or abstract
DOI
http://dx.doi.org/10.1093/annonc/mdy538
Revista
ANNALS OF ONCOLOGY
Títol Complet
Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab.
Factor d'impacte
14.20
Codi
11188
PMID
https://pubmed.ncbi.nlm.nih.gov/30624595
Nom Autors
Schneeweiss, A, Gianni, L, Gao, J J, Stein, A, Waldron-Lynch, M, Heeson, S, Beattie, M S, Yoo, B, Cortes, J, Baselga, J et al.
DOI número
10.1093/annonc/mdy538
Year
2019
Referencia
J Clin Oncol. 2019 Feb 20;37(6):490-503. doi: 10.1200/JCO.18.00358. Epub 2019 Jan 9.
Tipus publicació
Paper in international publication
DOI
http://dx.doi.org/10.1200/JCO.18.00358
Revista
JOURNAL OF CLINICAL ONCOLOGY
Títol Complet
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer.
Factor d'impacte
28.25
Codi
11189
PMID
https://pubmed.ncbi.nlm.nih.gov/30625039
Nom Autors
Montesa, Alvaro, Nombela, Paz, Fernandez-Parra, Eva, Gonzalez Del Alba, Aranzazu, Villa-Guzman, Jose Carlos, Ibanez, Kristina, Rodriguez-Vida, Alejo, Magraner-Pardo, Lorena, Perez-Valderrama, Begona, Vallespin, Elena et al.
DOI número
10.1200/JCO.18.00358
Year
2019
Referencia
Ann Oncol. 2019 Feb 1;30(2):161-165. doi: 10.1093/annonc/mdy553.
Tipus publicació
Paper in international publication
DOI
http://dx.doi.org/10.1093/annonc/mdy553
Revista
ANNALS OF ONCOLOGY
Títol Complet
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III Non-Small Cell Lung Cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP).
Factor d'impacte
14.20
Codi
11190
PMID
https://pubmed.ncbi.nlm.nih.gov/30624547
Nom Autors
Peters, Solange, Dafni, Urania, Boyer, Michael, De Ruysscher, Dirk, Faivre-Finn, Corinne, Felip, Enriqueta, Garrido, Pilar, Girard, Nicolas, Guckenberger, Matthias, Haanen, John et al.
DOI número
10.1093/annonc/mdy553
Year
2019
Referencia
Int J Cancer. 2019 Jul 15;145(2):401-414. doi: 10.1002/ijc.32114. Epub 2019 Feb 7.
Tipus publicació
Paper in international publication
DOI
http://dx.doi.org/10.1002/ijc.32114
Revista
INTERNATIONAL JOURNAL OF CANCER
Títol Complet
Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes.
Factor d'impacte
4.98
Codi
11191
PMID
https://pubmed.ncbi.nlm.nih.gov/30623411
Nom Autors
de la Hoya, Miguel, Spurdle, Amanda B, De Meyer, Tim, Blok, Marinus J, Investigators, KConFaB, Diez, Orland, Gutierrez-Enriquez, Sara, Vega, Ana, Brandao, Rita D, Mensaert, Klaas et al.
DOI número
10.1002/ijc.32114
Year
2019
Referencia
Oncologist. 2019 Jan;24(1):38-46. doi: 10.1634/theoncologist.2017-0622. Epub 2018 May 23.
Tipus publicació
Paper in international publication
DOI
http://dx.doi.org/10.1634/theoncologist.2017-0622
Revista
ONCOLOGIST
Títol Complet
Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR study.
Factor d'impacte
5.25
Codi
11192
PMID
https://pubmed.ncbi.nlm.nih.gov/29794066
Nom Autors
Capdevila, Jaume, Teule, Alexandre, Barriuso, Jorge, Castellano, Daniel, Lopez, Carlos, Manzano, Jose Luis, Alonso, Vicente, Garcia-Carbonero, Rocio, Dotor, Emma, Matos, Ignacio et al.
DOI número
10.1634/theoncologist.2017-0622